Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ambrosini

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
ESMO Open|June 10, 2026
Anti-EGFR-based maintenance versus stop and go in patients with left-sided, non-MSI-H, RAS/BRAF-wt metastatic colorectal cancer: individual patient data pooled analysisA Raimondi, G Tinè, V Boige, et al.
BMC Biology|April 13, 2019
Derivation of adult canine intestinal organoids for translational research in gastroenterologyLawrance Chandra, Dana C Borcherding, Dawn Kingsbury, et al.
International Journal of Pharmaceutics|May 25, 2024
Nanobody-liposomes as novel cancer vaccine platform to efficiently stimulate T cell immunityR G Bouma, M K Nijen Twilhaar, H J Brink, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Comparative efficacy of PD-1 blockade in patients with dMMR/MSI-H metastatic colorectal or gastric cancer: a global retrospective studyG Mazzoli, F Nichetti, K Shitara, et al.
The Journal of Experimental Medicine|June 18, 2014
CNS myelin induces regulatory functions of DC-SIGN-expressing, antigen-presenting cells via cognate interaction with MOGJ J García-Vallejo, J M Ilarregui, H Kalay, et al.
ESMO Open|June 20, 2025
Impact of age and sex on the efficacy and safety of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy: a subgroup analysis of the ARMANI phase III trialR Fazio, G Randon, F Bergamo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2024
Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancerM Ambrosini, B Rousseau, P Manca, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
ESMO Open|June 10, 2026
Anti-EGFR-based maintenance versus stop and go in patients with left-sided, non-MSI-H, RAS/BRAF-wt metastatic colorectal cancer: individual patient data pooled analysisA Raimondi, G Tinè, V Boige, et al.
BMC Biology|April 13, 2019
Derivation of adult canine intestinal organoids for translational research in gastroenterologyLawrance Chandra, Dana C Borcherding, Dawn Kingsbury, et al.
International Journal of Pharmaceutics|May 25, 2024
Nanobody-liposomes as novel cancer vaccine platform to efficiently stimulate T cell immunityR G Bouma, M K Nijen Twilhaar, H J Brink, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Comparative efficacy of PD-1 blockade in patients with dMMR/MSI-H metastatic colorectal or gastric cancer: a global retrospective studyG Mazzoli, F Nichetti, K Shitara, et al.
The Journal of Experimental Medicine|June 18, 2014
CNS myelin induces regulatory functions of DC-SIGN-expressing, antigen-presenting cells via cognate interaction with MOGJ J García-Vallejo, J M Ilarregui, H Kalay, et al.
ESMO Open|June 20, 2025
Impact of age and sex on the efficacy and safety of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy: a subgroup analysis of the ARMANI phase III trialR Fazio, G Randon, F Bergamo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2024
Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancerM Ambrosini, B Rousseau, P Manca, et al.
Pageof 8